What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Christopher P. Evans focuses on Immunology, Genetic enhancement, Cartilage, Arthritis and Pathology.
His biological study spans a wide range of topics, including In vitro and Cell biology.
His studies in Genetic enhancement integrate themes in fields like Ex vivo, In vivo, Cancer research and Molecular biology.
His work deals with themes such as Osteoarthritis, Synovial fluid and Growth factor, which intersect with Cartilage.
His Arthritis study is concerned with Internal medicine in general.
His Pathology research focuses on subjects like Bone healing, which are linked to Bone regeneration.
His most cited work include:
- Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies (2742 citations)
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy (1679 citations)
- Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer (737 citations)
What are the main themes of his work throughout his whole career to date?
Prostate cancer, Internal medicine, Cancer research, Genetic enhancement and Oncology are his primary areas of study.
Prostate cancer is a subfield of Cancer that Christopher P. Evans explores.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Surgery.
The study incorporates disciplines such as Pathology, Immunology, Arthritis and Bioinformatics in addition to Genetic enhancement.
Christopher P. Evans focuses mostly in the field of Immunology, narrowing it down to matters related to Cartilage and, in some cases, Cell biology and Osteoarthritis.
His Arthritis research includes themes of Clinical trial and Rheumatoid arthritis.
He most often published in these fields:
- Prostate cancer (19.04%)
- Internal medicine (19.20%)
- Cancer research (13.18%)
What were the highlights of his more recent work (between 2015-2021)?
- Prostate cancer (19.04%)
- Internal medicine (19.20%)
- Oncology (11.64%)
In recent papers he was focusing on the following fields of study:
Christopher P. Evans spends much of his time researching Prostate cancer, Internal medicine, Oncology, Cancer research and Enzalutamide.
The Prostate cancer study which covers Androgen that intersects with Intracrine.
In most of his Internal medicine studies, his work intersects topics such as Endocrinology.
His Oncology study combines topics in areas such as Biopsy and Surgery.
His research brings together the fields of Anti-Androgen and Cancer research.
In his work, Niclosamide is strongly intertwined with Abiraterone, which is a subfield of Enzalutamide.
Between 2015 and 2021, his most popular works were:
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 (333 citations)
- The Beaker phenomenon and the genomic transformation of northwest Europe (243 citations)
- The influence of eWOM in social media on consumers' purchase intentions (243 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Christopher P. Evans mainly investigates Prostate cancer, Internal medicine, Enzalutamide, Oncology and Cancer research.
His Prostate cancer study integrates concerns from other disciplines, such as Androgen, Pharmacology and Gene knockdown.
His Internal medicine study frequently intersects with other fields, such as Endocrinology.
His research integrates issues of Clinical trial, Placebo, Biopsy, Disease and Hazard ratio in his study of Oncology.
His Cancer research research is multidisciplinary, incorporating elements of Exome sequencing, Structural variation, Carcinogenesis, Unfolded protein response and Regulation of gene expression.
In his research on the topic of Cancer, Surgery is strongly related with Urology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
